NCT06564623 2025-12-05Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Recruiting25 enrolled
NCT06258304 2025-04-10A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesGigaGen, Inc.Phase 1 Recruiting60 enrolled